Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2025-12-31 @ 11:01 PM
Study NCT ID:
NCT03341494
Status:
UNKNOWN
Last Update Posted:
2017-11-14
First Post:
2017-11-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
EGFR Mutation Positive NSCLC Patients With Gefitinib and Thalidomide
Sponsor:
Fujian Cancer Hospital
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
CSWOG002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None